Yuanmeng Jin

687 total citations
24 papers, 493 citations indexed

About

Yuanmeng Jin is a scholar working on Nephrology, Molecular Biology and Immunology. According to data from OpenAlex, Yuanmeng Jin has authored 24 papers receiving a total of 493 indexed citations (citations by other indexed papers that have themselves been cited), including 18 papers in Nephrology, 7 papers in Molecular Biology and 5 papers in Immunology. Recurrent topics in Yuanmeng Jin's work include Renal Diseases and Glomerulopathies (13 papers), Chronic Kidney Disease and Diabetes (12 papers) and Complement system in diseases (3 papers). Yuanmeng Jin is often cited by papers focused on Renal Diseases and Glomerulopathies (13 papers), Chronic Kidney Disease and Diabetes (12 papers) and Complement system in diseases (3 papers). Yuanmeng Jin collaborates with scholars based in China, United States and Canada. Yuanmeng Jin's co-authors include John Cijiang He, Huabao Xiong, Weiming Wang, Jingyuan Xie, Nan Chen, Ruijie Liu, Nan Chen, Peter Y. Chuang, Vivette D. D’Agati and Hui Chen and has published in prestigious journals such as Nature Medicine, SHILAP Revista de lepidopterología and Kidney International.

In The Last Decade

Yuanmeng Jin

23 papers receiving 488 citations

Author Peers

Peers are selected by citation overlap in the author's most active subfields. citations · hero ref

Author						Papers	Cites
Yuanmeng Jin	220	197	86	65	50	24	493
Camille Macé	144 0.7×	408 2.1×	82 1.0×	55 0.8×	83 1.7×	15	653
Toshiya Okumura	167 0.8×	127 0.6×	136 1.6×	72 1.1×	77 1.5×	16	503
Lucía Tejedor-Santamaria	172 0.8×	72 0.4×	75 0.9×	27 0.4×	53 1.1×	22	415
Bihua Xu	237 1.1×	159 0.8×	219 2.5×	34 0.5×	52 1.0×	14	588
Jun Xue	187 0.8×	160 0.8×	84 1.0×	122 1.9×	109 2.2×	45	657
Anna Reznichenko	160 0.7×	97 0.5×	111 1.3×	60 0.9×	67 1.3×	18	445
S.P. Stoesz	212 1.0×	178 0.9×	34 0.4×	96 1.5×	30 0.6×	7	437
Motokazu Matsuura	195 0.9×	190 1.0×	35 0.4×	81 1.2×	59 1.2×	30	538
Hanna E. Abboud	185 0.8×	148 0.8×	93 1.1×	36 0.6×	44 0.9×	11	442
Yao He	328 1.5×	85 0.4×	61 0.7×	223 3.4×	32 0.6×	22	648

Countries citing papers authored by Yuanmeng Jin

Since Specialization

Citations

This map shows the geographic impact of Yuanmeng Jin's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Yuanmeng Jin with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Yuanmeng Jin more than expected).

Fields of papers citing papers by Yuanmeng Jin

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Yuanmeng Jin. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Yuanmeng Jin. The network helps show where Yuanmeng Jin may publish in the future.

Co-authorship network of co-authors of Yuanmeng Jin

This figure shows the co-authorship network connecting the top 25 collaborators of Yuanmeng Jin. A scholar is included among the top collaborators of Yuanmeng Jin based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Yuanmeng Jin. Yuanmeng Jin is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Weng, Qianfeng, Yan Ouyang, Zijin Chen, et al.. (2025). Efficacy and safety of telitacicept in IgA nephropathy: real-world study outcomes. Clinical Kidney Journal. 18(6). sfaf154–sfaf154. 4 indexed citations

Yu, Shuwen, Xiangchen Gu, Yunzi Liu, et al.. (2024). Tauroursodeoxycholic acid ameliorates renal injury induced by COL4A3 mutation. Kidney International. 106(3). 433–449. 10 indexed citations

Jin, Yuanmeng, et al.. (2024). PPAR gamma and PGC‐1alpha activators protect against diabetic nephropathy by suppressing the inflammation and NF‐kappaB activation. Nephrology. 29(12). 858–872. 14 indexed citations

Liu, Yunzi, Yuanmeng Jin, Hao Xu, et al.. (2023). Develop and Validate a Risk Score in Predicting Renal Failure in Focal Segmental Glomerulosclerosis. SHILAP Revista de lepidopterología. 9(4). 285–297.

Zhang, Chunli, Yuanmeng Jin, Jun Tong, et al.. (2022). Adult-Onset Focal Segmental Glomerulosclerosis With Steroid-Dependent Nephrotic Syndrome Caused by a Novel TBC1D8B Variant: A Case Report and Literature Review. American Journal of Kidney Diseases. 81(2). 240–244. 3 indexed citations

Hussain, Hafiz Muhammad Jafar, Qinjie Weng, Jun Tong, et al.. (2022). Mutation in XPO5 causes adult-onset autosomal dominant familial focal segmental glomerulosclerosis. Human Genomics. 16(1). 57–57. 1 indexed citations

Jin, Yuanmeng, Peter Y. Chuang, Ying Fan, et al.. (2021). Publisher Correction: A systems approach identifies HIPK2 as a key regulator of kidney fibrosis. Nature Medicine. 27(8). 1483–1483. 1 indexed citations

Ouyang, Yan, Zhanzheng Zhao, Guisen Li, et al.. (2021). A Validation Study Comparing Risk Prediction Models of IgA Nephropathy. Frontiers in Immunology. 12. 753901–753901. 16 indexed citations

Xiao, Wenzhen, Enxuan Jing, Bao Li, et al.. (2020). Tubular HIPK2 is a key contributor to renal fibrosis. JCI Insight. 5(17). 15 indexed citations

10.

Shi, Manman, Shuwen Yu, Yan Ouyang, et al.. (2020). Increased Lifetime Risk of ESRD in Familial IgA Nephropathy. Kidney International Reports. 6(1). 91–100. 8 indexed citations

11.

Tong, Jun, Yuanmeng Jin, Qinjie Weng, et al.. (2020). Glomerular Transcriptome Profiles in Focal Glomerulosclerosis: New Genes and Pathways for Steroid Resistance. American Journal of Nephrology. 51(6). 442–452. 7 indexed citations

12.

Weng, Qinjie, Qiongxiu Zhou, Jun Tong, et al.. (2020). New risk score for predicting steroid resistance in patients with focal segmental glomerulosclerosis or minimal change disease. Clinical Proteomics. 17(1). 18–18. 4 indexed citations

13.

Ouyang, Yan, Li Zhu, Manman Shi, et al.. (2019). A Rare Genetic Defect of MBL2 Increased the Risk for Progression of IgA Nephropathy. Frontiers in Immunology. 10. 537–537. 22 indexed citations

14.

Han, Lin, Bingbing Zhu, Hui Chen, et al.. (2019). Proteasome inhibitor MG132 inhibits the process of renal interstitial fibrosis. Experimental and Therapeutic Medicine. 17(4). 2953–2962. 5 indexed citations

15.

Jin, Yuanmeng, Ruijie Liu, Jingyuan Xie, et al.. (2013). Interleukin-10 deficiency aggravates kidney inflammation and fibrosis in the unilateral ureteral obstruction mouse model. Laboratory Investigation. 93(7). 801–811. 85 indexed citations

16.

Zhu, Bingbing, Yuanmeng Jin, Lin Han, et al.. (2013). Proteasome inhibitor inhibits proliferation and induces apoptosis in renal interstitial fibroblasts. Pharmacological Reports. 65(5). 1357–1365. 10 indexed citations

17.

Zhong, Fang, et al.. (2012). Analysis of the Gene Expression Profile of Curcumin-Treated Kidney on Endotoxin-Induced Renal Inflammation. Inflammation. 36(1). 80–93. 4 indexed citations

18.

Jin, Yuanmeng, Peter Y. Chuang, Ying Fan, et al.. (2012). A systems approach identifies HIPK2 as a key regulator of kidney fibrosis. Nature Medicine. 18(4). 580–588. 123 indexed citations

19.

Feng, Xiaobei, Peter Y. Chuang, Ting-Chi Lu, et al.. (2010). Role of the retinoic acid receptor-α in HIV-associated nephropathy. Kidney International. 79(6). 624–634. 58 indexed citations

20.

Wang, Weiming, Huidi Zhang, Yuanmeng Jin, Bingbing Zhu, & Nan Chen. (2008). PPAR-γ agonists inhibit TGF-β1-induced chemokine expression in human tubular epithelial cells. Acta Pharmacologica Sinica. 30(1). 107–112. 23 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact